NPC’s Dr. Dubois Answers: Are ACOs Ready to Manage Medications?

NPC Chief Science Officer Robert Dubois, MD, PhD, will present recommendations on how to optimally use medications to achieve success in value-based health during a panel at the Value-Based Payment and Pay for Performance Summit on Thursday, February 18 at 1:30 pm PT.

NPC Chief Science Officer Robert Dubois, MD, PhD, will present recommendations on how to optimally use medications to achieve success in value-based health during a panel at the Value-Based Payment and Pay for Performance Summit on Thursday, February 18 at 1:30 pm PT.

Dr. Dubois’ presentation builds off NPC’s research that examined accountable care organizations’ (ACO) capabilities to support, monitor and assure appropriate medication use in achieving the best patient health outcomes.

The ACOs included in the study reported strong capabilities to manage medications in a few areas, such as transmitting prescriptions electronically, being able to integrate medical and pharmacy data into a single database, and having a formulary in place that encourages generic use when appropriate.

However, ACOs also reported room for improvement in areas such as being able to identify the cost offsets and demonstrate the value of appropriate medication use, having protocols in place to avoid medication duplication and polypharmacy, and having quality metrics in place for a broad diversity of conditions. [Check out this study’s infographic and webinar.]

During his presentation at the Summit, Dr. Dubois also will propose tangible solutions to improve medication management and quality measures; highlight specific ACO case studies that NPC and its research partners, the American Medical Group Association and Premier, Inc., conducted on medication therapy management and electronic drug alert programs; and speak about the next installment of NPC’s “ACO Readiness Assessment 2.0.”

He will be joined by:

  • Hae Mi Choe, PharmD, Director of Pharmacy Innovations and Partnerships and Clinical Associate Professor of Pharmacy, University of Michigan Health System; and
  • David B. Muhlestein, PhD, JD, Senior Director of Research and Development, Leavitt Partners.

Register today to attend the Summit, which will be held at the Hyatt Regency San Francisco. If you can’t make it to San Francisco, the conference offers webcast attendance so you can watch it live from your office or home with 24/7 access for six months.